1MA.F
MACOM Technology Solutions Holdings, Inc.
FrankfurtEUREQUITY
Technology
DELAYED
Last price
227.20
▲ 0.20 (0.09%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
226.10
Prev close
227.00
Day high
228.20
Day low
224.80
Volume
30
Market cap
$17.35B
P/E (TTM)
84.78
52W range
104.00 – 376.60
Day trading desk
Gap from prior close
-0.40%
Prior close 227.00
VWAP
227.20
0.00% from price
Relative volume
2.00×
Unusually busy
Session range
1.51%
224.80 – 228.20
Position in range
71%
Near session high
ATR (14D)
14.04
6.18% of price
Prior day high
232.20
PDH
Prior day low
227.00
PDL
Bid / ask spread
—
Quote not published
Session volume
30
Avg 15
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-16.50%
-15.1%
1M
-6.54%
-10.3%
3M
-36.20%
-39.3%
6M
+10.29%
-0.8%
YTD
+55.62%
+43.3%
1Y
+112.34%
+92.3%
3Y
+204.97%
+130.8%
5Y
+313.09%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 1MA.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.00M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | KOBER JOHN F. III Chief Financial Officer |
SELL | 7.39K | $2.41M | Direct |
| Jun 25, 26 | HWANG DONGHYUN THOMAS Officer |
SELL | 2.62K | $1.01M | Direct |
| May 29, 26 | DALY STEPHEN G Chief Executive Officer |
SELL | 15.83K | $5.79M | Direct |
| May 19, 26 | BLAND CHARLES R Director |
STOCK | 700 | $0 | Direct |
| May 19, 26 | SHANMUGARAJ MURUGESAN Director |
STOCK | 1.40K | $0 | Direct |
| May 18, 26 | KOBER JOHN F. III Chief Financial Officer |
SELL | 7.64K | $2.75M | Direct |
| May 18, 26 | HWANG DONGHYUN THOMAS Officer |
SELL | 2.60K | $935.87K | Direct |
| May 15, 26 | HWANG DONGHYUN THOMAS Officer |
STOCK | 85 | $31.93K | Direct |
| May 15, 26 | KOBER JOHN F. III Chief Financial Officer |
STOCK | 108 | $40.56K | Direct |
| May 15, 26 | DENNEHY ROBERT B Chief Operating Officer |
STOCK | 146 | $54.84K | Direct |
| May 14, 26 | CHUNG PETER Y Director |
SELL | 43.27K | $16.36M | Indirect |
| May 13, 26 | BLAND CHARLES R Director |
SELL | 800 | $304.00K | Direct |
| May 11, 26 | RIBAR GEOFFREY GEORGE Director |
SELL | 1.62K | $587.27K | Direct |
| Apr 30, 26 | HWANG DONGHYUN THOMAS Officer |
SELL | 3.72K | $1.03M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLAND CHARLES R |
Director | 13.64K | Stock Gift |
DALY STEPHEN G |
Chief Executive Officer | 38.39K | Sale |
DENNEHY ROBERT B |
Chief Operating Officer | 13.01K | Stock Award(Grant) |
HWANG DONGHYUN THOMAS |
Officer | 29.76K | Sale |
KOBER JOHN F. III |
Chief Financial Officer | 33.58K | Sale |
OCAMPO SUSAN |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
RIBAR GEOFFREY GEORGE |
Director | 12.56K | Sale |
RITCHIE JOHN |
Director | 9.47K | Stock Award(Grant) |
ROTH AMBRA R |
General Counsel | 9.84K | Sale |
STRUBLE WAYNE MACK |
Officer | 29.38K | Stock Award(Grant) |
Fundamentals
Market cap$17.35B
Enterprise value$17.10B
Revenue (TTM)$1.16B
Gross profit$658.07M
EBITDA$276.05M
Net income$240.93M
EPS (TTM)$2.68
Free cash flow$104.35M
Total cash$663.03M
Total debt$414.05M
Book value / share$17.26
Shares outstanding76.37M
Float71.29M
Short % of float—
Dividend yield—
Beta (5Y)1.71
Valuation & profitability ratios
Trailing P/E84.78
Forward P/E92.36
PEG ratio2.05
Price / sales—
Price / book13.16
EV / revenue14.69
EV / EBITDA61.95
Gross margin56.54%
Operating margin23.34%
Profit margin20.70%
Return on equity17.18%
Return on assets6.38%
Debt / equity26.87
Current ratio2.34
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $967.26M | $729.58M | $648.41M | $675.17M | — | +32.6% |
| Operating revenue | $967.26M | $729.58M | $648.41M | $675.17M | — | +32.6% |
| Cost of revenue | $438.26M | $335.81M | $262.61M | $268.99M | — | +30.5% |
| Gross profit | $529.00M | $393.77M | $385.80M | $406.18M | — | +34.3% |
| Research & development | $244.47M | $182.16M | $148.54M | $148.23M | — | +34.2% |
| Selling, general & admin | $154.88M | $137.95M | $129.85M | $125.28M | — | +12.3% |
| Total operating expense | $399.35M | $320.11M | $278.40M | $273.51M | — | +24.8% |
| Operating income | $129.65M | $73.67M | $107.40M | $132.67M | — | +76.0% |
| Net interest income | $24.34M | $17.85M | $8.42M | -$4.30M | — | +36.3% |
| Pre-tax income | -$29.02M | $91.53M | $115.16M | $243.12M | — | -131.7% |
| Tax provision | $25.18M | $14.67M | $23.58M | -$196.84M | — | +71.7% |
| Net income | -$54.21M | $76.86M | $91.58M | $439.95M | — | -170.5% |
| Net income to common | -$54.21M | $76.86M | $91.58M | $439.95M | — | -170.5% |
| Basic EPS | — | 1.07 | 1.29 | 6.30 | 0.55 | — |
| Diluted EPS | — | 1.04 | 1.28 | 6.18 | 0.54 | — |
| EBIT | -$23.51M | $96.66M | $127.54M | $251.67M | — | -124.3% |
| EBITDA | $39.79M | $163.91M | $179.69M | $308.90M | — | -75.7% |
| Basic shares | — | 71.96M | 70.80M | 69.78M | 68.45M | — |
| Diluted shares | — | 73.58M | 71.50M | 71.17M | 70.47M | — |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $112.14M | $146.81M | $173.95M | $119.95M | -23.6% |
| Cash & short-term investments | $785.98M | $581.89M | $514.53M | $586.53M | +35.1% |
| Accounts receivable | $148.65M | $105.70M | $91.25M | $101.55M | +40.6% |
| Inventory | $237.84M | $194.49M | $136.30M | $114.96M | +22.3% |
| Total current assets | $1.21B | $903.08M | $761.19M | $813.08M | +33.4% |
| Property, plant & equipment | $230.29M | $176.02M | $149.50M | $123.70M | +30.8% |
| Goodwill & intangibles | $414.88M | $408.29M | $390.39M | $362.67M | +1.6% |
| Total assets | $2.10B | $1.76B | $1.55B | $1.57B | +19.8% |
| Total current liabilities | $325.12M | $108.18M | $83.53M | $97.21M | +200.5% |
| Current debt | $160.95M | — | — | — | — |
| Long-term debt | $339.63M | $448.28M | $447.13M | $565.92M | -24.2% |
| Total debt | $537.99M | $487.78M | $487.33M | $600.43M | +10.3% |
| Total liabilities | $776.26M | $629.30M | $605.64M | $729.07M | +23.4% |
| Retained earnings | -$240.06M | -$185.85M | -$262.71M | -$354.29M | -29.2% |
| Shareholder equity | $1.33B | $1.13B | $947.60M | $842.75M | +17.8% |
| Working capital | $879.97M | $794.89M | $677.67M | $715.87M | +10.7% |
| Net tangible assets | $912.21M | $718.05M | $557.21M | $480.08M | +27.0% |
| Shares issued | 74.50M | 72.22M | 71.01M | 70.02M | +3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$54.21M | $76.86M | $91.58M | $439.95M | -170.5% |
| Depreciation & amortisation | $63.30M | $67.25M | $52.15M | $57.23M | -5.9% |
| Stock-based compensation | $79.36M | $45.64M | $38.10M | $41.19M | +73.9% |
| Change in working capital | -$37.79M | -$31.03M | -$27.77M | -$46.69M | -21.8% |
| Operating cash flow | $235.37M | $162.64M | $166.92M | $176.98M | +44.7% |
| Capital expenditure | -$82.17M | -$25.63M | -$24.70M | -$26.51M | -220.6% |
| Investing cash flow | -$328.26M | -$181.13M | $36.34M | -$182.86M | -81.2% |
| Share buybacks | -$43.13M | -$14.22M | -$32.62M | -$36.00M | -203.4% |
| Financing cash flow | $58.10M | -$9.06M | -$149.02M | -$28.91M | +741.0% |
| Free cash flow | $153.20M | $137.01M | $142.22M | $150.47M | +11.8% |
| End cash position | $112.14M | $146.81M | $173.95M | $119.95M | -23.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $342.24M | $288.95M | $271.61M | $261.17M | $252.08M | — | +18.4% |
| Operating revenue | $342.24M | $288.95M | $271.61M | $261.17M | $252.08M | — | +18.4% |
| Cost of revenue | $142.69M | $124.52M | $119.83M | $118.87M | $112.64M | — | +14.6% |
| Gross profit | $199.55M | $164.43M | $151.78M | $142.30M | $139.44M | — | +21.4% |
| Research & development | $74.31M | $68.98M | $66.46M | $62.88M | $63.38M | — | +7.7% |
| Selling, general & admin | $48.13M | $44.62M | $42.02M | $39.83M | $38.40M | — | +7.9% |
| Total operating expense | $122.44M | $113.60M | $108.48M | $102.71M | $101.78M | — | +7.8% |
| Operating income | $77.11M | $50.83M | $43.30M | $39.59M | $37.66M | — | +51.7% |
| Net interest income | $5.19M | $6.09M | $6.29M | $6.22M | $6.42M | — | -14.8% |
| Pre-tax income | $123.85M | $56.92M | $49.59M | $55.90M | $44.08M | — | +117.6% |
| Tax provision | $23.14M | $10.59M | $822.00K | $10.78M | $7.55M | — | +118.5% |
| Net income | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | — | +117.4% |
| Net income to common | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | — | +117.4% |
| Basic EPS | 1.32 | 0.62 | 0.65 | — | 0.49 | 0.43 | +112.9% |
| Diluted EPS | 1.28 | 0.60 | 0.64 | — | 0.48 | 0.42 | +113.3% |
| EBIT | $125.33M | $58.59M | $51.29M | $57.70M | $45.26M | — | +113.9% |
| EBITDA | $140.99M | $74.23M | $66.67M | $75.34M | $60.10M | — | +89.9% |
| Basic shares | 76.33M | 75.28M | 74.82M | — | 74.43M | 74.36M | +1.4% |
| Diluted shares | 78.41M | 77.56M | 76.72M | — | 75.86M | 75.74M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $89.60M | $98.52M | $119.65M | $112.14M | $125.47M | — | -9.1% |
| Cash & short-term investments | $663.03M | $664.86M | $768.49M | $785.98M | $735.23M | — | -0.3% |
| Accounts receivable | $179.15M | $159.60M | $160.06M | $148.65M | $129.49M | — | +12.2% |
| Inventory | $281.52M | $252.19M | $238.91M | $237.84M | $215.39M | — | +11.6% |
| Total current assets | $1.17B | $1.13B | $1.21B | $1.21B | $1.13B | — | +4.1% |
| Property, plant & equipment | $246.31M | $234.96M | $234.71M | $230.29M | $208.99M | — | +4.8% |
| Goodwill & intangibles | $396.96M | $402.99M | $408.54M | $414.88M | $411.82M | — | -1.5% |
| Total assets | $2.15B | $2.01B | $2.11B | $2.10B | $2.00B | — | +6.6% |
| Total current liabilities | $501.51M | $149.70M | $304.54M | $325.12M | $294.65M | — | +235.0% |
| Current debt | $340.46M | — | $160.56M | $160.95M | $160.84M | $160.74M | — |
| Long-term debt | — | $340.19M | $339.91M | $339.63M | $339.35M | $339.07M | — |
| Total debt | $377.49M | $377.31M | $531.45M | $537.99M | $531.55M | — | +0.0% |
| Total liabilities | $605.99M | $596.82M | $752.41M | $776.26M | $739.92M | — | +1.5% |
| Retained earnings | -$44.25M | -$144.96M | -$191.29M | -$240.06M | -$285.18M | — | +69.5% |
| Shareholder equity | $1.54B | $1.42B | $1.35B | $1.33B | $1.26B | — | +8.7% |
| Working capital | $670.77M | $976.35M | $901.47M | $879.97M | $832.71M | — | -31.3% |
| Net tangible assets | $1.14B | $1.01B | $944.58M | $912.21M | $851.53M | — | +12.7% |
| Shares issued | 76.39M | 76.32M | 75.03M | 74.50M | 74.49M | — | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $100.71M | $46.33M | $48.77M | $45.12M | $36.53M | +117.4% |
| Depreciation & amortisation | $15.65M | $15.64M | $15.38M | $17.65M | $14.85M | +0.1% |
| Stock-based compensation | $21.10M | $22.64M | $22.14M | $17.77M | $17.31M | -6.8% |
| Change in working capital | -$35.55M | -$11.29M | -$42.70M | -$3.53M | -$12.38M | -214.8% |
| Operating cash flow | $79.96M | $78.66M | $42.92M | $69.64M | $60.39M | +1.6% |
| Capital expenditure | -$82.79M | -$16.28M | -$17.26M | -$31.09M | -$38.63M | -408.4% |
| Investing cash flow | -$89.96M | $64.75M | $8.77M | -$82.13M | -$79.00M | -238.9% |
| Share buybacks | — | — | — | -$451.00K | — | — |
| Financing cash flow | $1.21M | -$164.50M | -$44.20M | -$697.00K | $32.51M | +100.7% |
| Free cash flow | -$2.83M | $62.38M | $25.66M | $38.55M | $21.76M | -104.5% |
| End cash position | $89.60M | $98.52M | $119.65M | $112.14M | $125.47M | -9.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $420.35M | +61.0% |
| Next quarter | — | — | $429.91M | +58.3% |
| Current year | — | — | $1.32B | +36.9% |
| Next year | — | — | $1.80B | +35.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders6.55%
Held by institutions97.56%
Institutions holding872
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
253.91
-10.52% from price
SMA 20
241.30
-5.84% from price
SMA 50
268.38
-15.34% from price
SMA 100
272.24
-16.54% from price
SMA 200
222.75
+2.00% from price
EMA 12
245.61
-7.50% from price
EMA 26
250.11
-9.16% from price
EMA 50
258.60
-12.14% from price
RSI (14)
41.1
Neutral
MACD (12,26,9)
-4.51
Hist -0.84
ATR (14)
14.04
6.18% of price
Realised vol 30D
81.6%
Annualised
Bollinger upper
287.28
20, 2σ
Bollinger lower
195.33
20, 2σ
50 / 200 cross
Golden
268.38 vs 222.75
Trend bias
Above 200
+2.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.40
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
81.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-44.3%
Peak to trough
Max drawdown 5Y
-44.3%
Peak to trough
ATR 14
14.04
6.18% of price
Beta (reported)
1.71
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | BMO Capital | INITIATED | — | Market Perform |
| Aug 7, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Susquehanna | MAINTAINED | Neutral | Neutral |
| Jun 24, 26 | Stifel | MAINTAINED | Buy | Buy |
| May 22, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 8, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 8, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 8, 26 | Susquehanna | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Needham | MAINTAINED | Buy | Buy |
Headlines
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 15m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 16m ago
Liverpool striker Isak expected Newcastle abuse, says Iraola
AFP · 16m ago
Your mortgage rate has a growing problem in the bond market
TheStreet · 18m ago
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Insider Monkey · 22m ago
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 25m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 26m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.